Enliven Therapeutics Inc. (ELVN)

Market is closed
Insider Trading: Purchases
Insider Price Amount Relationship Remaining Holdings Date Form 4
$22.07 622 Large Shareholder 718,749 2023-02-23 Filing
$5.11 23,565 Large Shareholder 2,872,513 2023-02-22 Filing
$5.25 8,194 Large Shareholder 2,848,948 2023-02-21 Filing
$4.00 629,297 Large Shareholder 3,880,021 2023-01-03 Filing
$3.93 19,299 Large Shareholder 3,250,724 2022-12-09 Filing
$3.75 10,600 Large Shareholder 3,231,425 2022-12-08 Filing
$3.91 26,460 Large Shareholder 3,220,825 2022-10-24 Filing
$3.92 48,100 Large Shareholder 3,194,365 2022-10-21 Filing
$3.95 11,342 Large Shareholder 3,146,265 2022-10-20 Filing
$3.89 125,726 Large Shareholder 3,134,923 2022-10-19 Filing
$3.76 234,799 Large Shareholder 3,009,197 2022-10-18 Filing
$3.36 145,672 Large Shareholder 2,774,398 2022-10-17 Filing
$1.11 83,199 Large Shareholder 3,017,774 2022-06-16 Filing
$1.16 2,630 Large Shareholder 2,934,575 2022-06-06 Filing
$1.14 30,800 Large Shareholder 2,931,945 2022-06-03 Filing
$1.26 26,145 Large Shareholder 2,901,145 2022-05-17 Filing
$1.17 15,000 Large Shareholder 2,875,000 2022-05-16 Filing
$1.38 8,000 Large Shareholder 2,860,000 2022-04-22 Filing
$1.40 552,000 Large Shareholder 2,852,000 2022-04-21 Filing
$1.46 35,257 Director 229,224 2022-02-23 Filing